Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.325 CAD | 0.00% | -7.14% | -16.67% |
May. 15 | Microbix Biosystems Up More Than 10% As Q2 Profit Grows On Higher Revenues; Says Stage Set For Record FY | MT |
May. 15 | Transcript : Microbix Biosystems Inc., Q2 2024 Earnings Call, May 15, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.67% | 32.55M | |
+63.00% | 62.59B | |
-2.04% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+12.18% | 26.21B | |
-21.88% | 19.09B | |
+3.53% | 13.08B | |
+25.49% | 12.26B | |
+27.30% | 12.05B |
- Stock Market
- Equities
- MBX Stock
- News Microbix Biosystems Inc.
- Microbix Brief: Unveiling Test Controls for Head and Neck Cancer